404
Anti Depressant Market Report
Anti-Depressant Market Trends, Dynamics & Market Insights
Anti-Depressant Market, By Product (Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Serotonin Antagonist, Reuptake Inhibitors, Others), End-User (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, Others), and Region ...
The anti-depressant market is expected to witness an impressive growth of 3.4% CAGR in the coming years.
Alkermes (Ireland), Allergan, Inc. (Ireland), Bristol Myers Squibb (US), Eli Lilly and Company (US), GlaxoSmithKline plc (UK), H. Lundbeck A/S (Denmark), The Merck Group (Germany), Pfiz-er Inc. (US), Teva Pharmaceutical Industries Ltd. (Israel) and The Takeda Pharmaceutical Company Limited (Japan) are among the key players in the anti-depressant market.
The anti-depressant market size is expected to reach USD 17.5 billion in the foreseeable future.
North America is expected to grow at a significant CAGR in the anti-depressant market in the next five years.
The major depressive disorder segment accounted for the largest share in the anti-depressant market in 2020.
Anti-depressant distributors, Anti-depressant suppliers, Anti-depressant manufacturers, Logistics organizations, Government bodies are the target audience in the anti-depressant market.